Assessment and Detection of Early Lung Disease in Cystic Fibrosis

Area of Science:

• Pulmonary Medicine
• Pediatric Respiratory Diseases

Background:

• Cystic fibrosis (CF) lung disease is recognized to begin in infancy, with early structural, functional, and inflammatory changes present even in asymptomatic children.
• Widespread newborn screening for CF facilitates opportunities for primary prevention of lung disease.

Purpose of the Study:

• To review existing and novel testing modalities for identifying and monitoring mild CF lung disease in infants and young children.
• To highlight the need for sensitive, non-invasive tests capable of detecting early peripheral airway disease and therapeutic responses.

Main Methods:

• Review of current literature on pulmonary function testing, structural imaging, pathogen identification, and inflammation detection in pediatric CF.
• Focus on modalities suitable for early detection, tracking disease progression, and assessing treatment efficacy in young children.

Main Results:

• Early-stage CF lung disease exhibits heterogeneity, often affecting peripheral airways.
• Sensitive testing is required to detect subtle changes indicative of disease progression or treatment response.
• Ideal tests should be non-sedated, safe for repeated use, and sensitive to early disease markers.

Conclusions:

• Primary prevention of CF lung disease is achievable through early intervention before symptom onset.
• Development and application of sensitive testing modalities are critical for managing CF lung disease in infancy and early childhood.
• Continued research into novel diagnostic tools is essential for optimizing CF care in young populations.